Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Virgolini

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2015
Peptide receptor radionuclide therapy (PRRT): clinical significance of re-treatment?Irene Virgolini,
World Journal of Nuclear Medicine|May 3, 2018
Greetings from the New President of the World Association of Radiopharmaceutical and Molecular TherapyIrene Virgolini
The Lancet. Oncology|November 18, 2021
Overall survival results from the NETTER-1 trial in neuroendocrine tumours: an important milestoneIrene Virgolini
European Journal of Nuclear Medicine and Molecular Imaging|May 19, 2019
University Professor Emeritus Dr. Georg RiccabonaIrene Virgolini
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2011
Diagnosis and therapy are walking together on radiopeptides' avenueLuigi Mansi, Irene Virgolini
PET Clinics|May 31, 2021
Theragnostics in Neuroendocrine TumorsMargarida Rodrigues, Hanna Svirydenka, Irene Virgolini
Thyroid : Official Journal of the American Thyroid Association|January 21, 2006
Reference values for thyrotropinRoy Moncayo, Helga Moncayo, Irene Virgolini
PET Clinics|March 29, 2023
Imaging FibrosisAnna Sviridenko, Gianpaolo di Santo, Irene Virgolini
Seminars in Nuclear Medicine|March 15, 2024
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and AlternativesGiulia Santo, Gianpaolo Di Santo, Irene Virgolini
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2005
Nuclear medicine in the detection and management of pancreatic islet-cell tumoursIrene Virgolini, Tatjana Traub-Weidinger, Clemens Decristoforo
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2015
Peptide receptor radionuclide therapy (PRRT): clinical significance of re-treatment?Irene Virgolini,
World Journal of Nuclear Medicine|May 3, 2018
Greetings from the New President of the World Association of Radiopharmaceutical and Molecular TherapyIrene Virgolini
The Lancet. Oncology|November 18, 2021
Overall survival results from the NETTER-1 trial in neuroendocrine tumours: an important milestoneIrene Virgolini
European Journal of Nuclear Medicine and Molecular Imaging|May 19, 2019
University Professor Emeritus Dr. Georg RiccabonaIrene Virgolini
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2011
Diagnosis and therapy are walking together on radiopeptides' avenueLuigi Mansi, Irene Virgolini
PET Clinics|May 31, 2021
Theragnostics in Neuroendocrine TumorsMargarida Rodrigues, Hanna Svirydenka, Irene Virgolini
Thyroid : Official Journal of the American Thyroid Association|January 21, 2006
Reference values for thyrotropinRoy Moncayo, Helga Moncayo, Irene Virgolini
PET Clinics|March 29, 2023
Imaging FibrosisAnna Sviridenko, Gianpaolo di Santo, Irene Virgolini
Seminars in Nuclear Medicine|March 15, 2024
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and AlternativesGiulia Santo, Gianpaolo Di Santo, Irene Virgolini
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2005
Nuclear medicine in the detection and management of pancreatic islet-cell tumoursIrene Virgolini, Tatjana Traub-Weidinger, Clemens Decristoforo
Pageof 13